PI
SNDX icon

PEAK6 Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

PEAK6 Investments’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$832K Hold
43,213
– – ﹤0.01% 2030
2024
Q2 		$887K Buy
43,213
+20,172
+88% +$422K ﹤0.01% 1914
2024
Q1 		$548K Buy
23,041
+5,500
+31% +$123K ﹤0.01% 2383
2023
Q4 		$379K Buy
17,541
+1,541
+10% +$23.7K ﹤0.01% 2813
2023
Q3 		$232K Hold
16,000
– – ﹤0.01% 2968
2023
Q2 		$335K Buy
+16,000
New +$333K ﹤0.01% 2502
2022
Q3 		– Sell
-16,000
Closed -$335K – 6027
2022
Q2 		$335K Buy
+16,000
New +$267K ﹤0.01% 4242

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return